Decreased S100B expression in chronic liver diseases
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Hepatic innervation in liver diseases is not fully understood. We here evaluated S100B expression as a marker of hepatic nerves in patients with various chronic liver diseases, topographically and semi-quantitatively. Methods: Liver specimens were obtained from 70 subjects (three controls, and 32 chronic hepatitis B, 14 chronic hepatitis C, 14 liver cirrhosis, and seven hepatocellular carcinoma patients). The hepatic nerve density was calculated based on immunohistochemical staining of S100B protein in the portal tracts and hepatic lobules. S100B mRNA levels were semi-quantitatively assessed as the S100B/glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA ratio. Results: The densities of the hepatic nerves in portal tracts of chronic liver diseases were not significantly different from those of normal controls but the hepatic nerve densities in lobular areas of liver cirrhosis were significantly decreased (p = 0.025). Compared to the control, the S100B/GAPDH mRNA ratio was significantly decreased in chronic liver diseases (p = 0.006) and most decreased in chronic hepatitis C patients (p = 0.023). In chronic liver diseases, The S100B/ GAPDH mRNA ratio tended to decrease as the fibrosis score > 0 (p = 0.453) but the overall correlation between the S100B/GAPDH mRNA ratio and fibrosis score was not statistically significant (r = 0.061, p = 0.657). Conclusions: Hepatic innervation is decreased in cirrhotic regenerating nodules compared to the control group and seems to decrease in early stages of fibrosis progression. Further studies are needed to clarify the association between changes of hepatic innervation and chronic liver disease progression.
Abstract
Background/Aims: Hepatic innervation in liver diseases is not fully understood. We here evaluated S100B expression as a marker of hepatic nerves in patients with various chronic liver diseases, topographically and semi-quantitatively. Methods: Liver specimens were obtained from 70 subjects (three controls, and 32 chronic hepatitis B, 14 chronic hepatitis C, 14 liver cirrhosis, and seven hepatocellular carcinoma patients). The hepatic nerve density was calculated based on immunohistochemical staining of S100B protein in the portal tracts and hepatic lobules. S100B mRNA levels were semi-quantitatively assessed as the S100B/glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA ratio. Results: The densities of the hepatic nerves in portal tracts of chronic liver diseases were not significantly different from those of normal controls but the hepatic nerve densities in lobular areas of liver cirrhosis were significantly decreased (p = 0.025). Compared to the control, the S100B/GAPDH mRNA ratio was significantly decreased in chronic liver diseases (p = 0.006) and most decreased in chronic hepatitis C patients (p = 0.023). In chronic liver diseases, The S100B/ GAPDH mRNA ratio tended to decrease as the fibrosis score > 0 (p = 0.453) but the overall correlation between the S100B/GAPDH mRNA ratio and fibrosis score was not statistically significant (r = 0.061, p = 0.657). Conclusions: Hepatic innervation is decreased in cirrhotic regenerating nodules compared to the control group and seems to decrease in early stages of fibrosis progression. Further studies are needed to clarify the association between changes of hepatic innervation and chronic liver disease progression.
참고문헌 (23)
- Tiniakos DG, "Innervation of the liver:morphology and function", Liver, 16, pp.151~160 (1996)
- Miyazawa Y, "Immunohistochemical studies on the distribution of nerve fibers in chronic liver diseases", Am J Gastroenterol, 83, pp.1108~1114 (1988)
- Henriksen JH, "The sympathetic nervous system in liver disease", J Hepatol, 29, pp.328~341 (1998)
- Hartmann H, "Direct control of glycogen metabolism in the perfused rat liver by the sympathetic innervation", Eur J Biochem, 123, pp.521~526 (1982)
- Gardemann A, "Nervous control of liver metabolism and hemodynamics", Eur J Biochem, 207, pp.399~411 (1992)
- Donato R., "Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type", Biochim Biophys Acta, 1450, pp.191~231 (1999)
- Ribeiro L, "Oxidative stress and S100B protein in cirrhotic children", Neurochem Res, 32, pp.1600~1603 (2007)
- Strauss GI, "S-100b and neuron-specific enolase in patients with fulminant hepatic failure", Liver Transpl, 7, pp.964~970 (2001)
- Donato R, "Specific binding sites for S-100 protein in isolated brain nuclei", J Neurochem, 36, pp.1698~1705 (1981)
- Matus A, "Immunohistochemical localisation of S-100 protein in brain", Nature, 258, pp.746~748 (1975)
- Soon Woo Nam, "Decreased Hepatic Nerve Fiber Innervation in Patients with Liver Cirrhosis", Gut and Liver, 1(2), pp.165~170 (2007), 거트앤리버 발행위원회
- Knodell RG, "Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis", Hepatology, 1, pp.431~435 (1981)
- Yamada E., "Some observations on the nerve terminal on the liver parenchymal cell of the mouse as revealed by electron microscopy", Okajimas Folia Anat Jpn, 40, pp.663~677 (1965)
- Streba LA, "Role of intrahepatic innervation in regulating the activity of liver cells", World J Hepatol, 6, pp.137~143 (2014)
- Terada T, "Innervation of intrahepatic bile ducts and peribiliary glands in normal human livers, extrahepatic biliary obstruction and hepatolithiasis: an immunohistochemical study", J Hepatol, 9, pp.141~148 (1989)
- Ueno T, "Innervation of the sinusoidal wall: regulation of the sinusoidal diameter", Anat Rec A Discov Mol Cell Evol Biol, 280, pp.868~873 (2004)
- Terada T, "S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma:an immunohistochemical study", Pathol Int, 51, pp.89~93 (2001)
- Matsunaga Y, "Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis", Am J Gastroenterol, 94, pp.1923~1932 (1999)
- Ungvary G, "Changes of the peripheral autonomic nervous system in altered internal environment", Z Mikrosk Anat Forsch, 94, pp.985~998 (1980)
- Rappaport AM, "The scarring of the liver acini (Cirrhosis): tridimensional and microcirculatory considerations", Virchows Arch A Pathol Anat Histopathol, 402, pp.107~137 (1983)
- Fukuda Y, "Immunohistochemical studies on structural changes of the hepatic lobules in chronic liver diseases", Am J Gastroenterol, 81, pp.1149~1155 (1986)
- Lee JA, "Disappearance of hepatic parenchymal nerves in human liver cirrhosis", Gut, 33, pp.87~91 (1992)
- Jaskiewicz K, "Distribution of hepatic nerve fibers in liver diseases", Digestion, 55, pp.247~252 (1994)